Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

January 2014 - FRMC

Evaluation of Errors When Using e-Prescribing
01/21/2014
San Antonio—While electronic prescribing (e-prescribing) has been widely recommended for its ability to reduce medication errors, especially transcription errors; however, according to recent study literature, the rates of e-prescribing...
San Antonio—While electronic prescribing (e-prescribing) has been widely recommended for its ability to reduce medication errors, especially transcription errors; however, according to recent study literature, the rates of e-prescribing...
San Antonio—While electronic...
01/21/2014
First Report Managed Care
Alternative Distribution Strategies: “Buy and Bill” and “White Bagging”
01/21/2014
When handling specialty drugs, physicians typically purchase the medications directly from distributors, administer them to patients, and then bill payers.
When handling specialty drugs, physicians typically purchase the medications directly from distributors, administer them to patients, and then bill payers.
When handling specialty drugs,...
01/21/2014
First Report Managed Care
Stenting Added to Medical Therapy for Atherosclerotic Renal Artery Stenosis
01/21/2014
Dallas—Stenting added to medical therapy did not reduce the rate of major cardiovascular and renal events compared with medical therapy alone in patients with atherosclerotic renal artery stenosis and hypertension or chronic kidney disease,...
Dallas—Stenting added to medical therapy did not reduce the rate of major cardiovascular and renal events compared with medical therapy alone in patients with atherosclerotic renal artery stenosis and hypertension or chronic kidney disease,...
Dallas—Stenting added to medical...
01/21/2014
First Report Managed Care
Edoxaban Versus Warfarin for Patients with AF
01/21/2014
Dallas—A randomized, double-blind trial that included patients with atrial fibrillation (AF) found that 2, once-daily doses of edoxaban were noninferior to warfarin in preventing strokes or systemic embolic events. Patients who received...
Dallas—A randomized, double-blind trial that included patients with atrial fibrillation (AF) found that 2, once-daily doses of edoxaban were noninferior to warfarin in preventing strokes or systemic embolic events. Patients who received...
Dallas—A randomized,...
01/21/2014
First Report Managed Care
Combination of Treatment for PAD Yielded Better Results
01/21/2014
Dallas—Patients with peripheral arterial disease (PAD) and intermittent claudication who underwent endovascular revascularization and supervised exercise therapy had a significant improvement in walking distance and quality of life compared...
Dallas—Patients with peripheral arterial disease (PAD) and intermittent claudication who underwent endovascular revascularization and supervised exercise therapy had a significant improvement in walking distance and quality of life compared...
Dallas—Patients with peripheral...
01/21/2014
First Report Managed Care
High Frequency Source Ablation Similar to Standard Treatment for AF
01/21/2014
Dallas—A prospective, multi-center, single-blind, randomized trial found that patients with paroxysmal, symptomatic, drug-refractory atrial fibrillation (AF) had no significant difference in freedom from AF or atrial tachyarrhythmias after 1...
Dallas—A prospective, multi-center, single-blind, randomized trial found that patients with paroxysmal, symptomatic, drug-refractory atrial fibrillation (AF) had no significant difference in freedom from AF or atrial tachyarrhythmias after 1...
Dallas—A prospective,...
01/21/2014
First Report Managed Care
CATIS Trial on Blood Pressure Reduction
01/21/2014
Dallas—Previous clinical trials have found that lowering blood pressure (BP) reduces the risk of stroke in hypertensive and normotensive patients with a history of stroke or transient ischemic attack. However, the effect of antihypertensive...
Dallas—Previous clinical trials have found that lowering blood pressure (BP) reduces the risk of stroke in hypertensive and normotensive patients with a history of stroke or transient ischemic attack. However, the effect of antihypertensive...
Dallas—Previous clinical trials...
01/21/2014
First Report Managed Care
Ibrutinib to Treat CLL/SLL
01/21/2014
New Orleans—After at least a year of treatment with ibrutinib, more than 80% of patients with treatment-naïve or relapsed/refractory chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL) had a partial or complete response,...
New Orleans—After at least a year of treatment with ibrutinib, more than 80% of patients with treatment-naïve or relapsed/refractory chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL) had a partial or complete response,...
New Orleans—After at least a...
01/21/2014
First Report Managed Care

Department

Conference Insider
Low Adherence Rates for Patients with Severe Hemophilia
01/21/2014
San Antonio—Prophylaxis with factor VII or IX has been shown to reduce bleeding episodes for patients with hemophilia A and B; however, a recent study finds that most individuals with severe hemophilia are not adherent to a routine...
San Antonio—Prophylaxis with factor VII or IX has been shown to reduce bleeding episodes for patients with hemophilia A and B; however, a recent study finds that most individuals with severe hemophilia are not adherent to a routine...
San Antonio—Prophylaxis with...
01/21/2014
First Report Managed Care
Conference Insider
Long-Term Results of Evolocumab to Treat Hypercholesterolemia
01/21/2014
Dallas—After a year of treatment, patients with hypercholesterolemia who received evolocumab plus the standard of care had a mean reduction of 50% in low-density lipoprotein (LDL) cholesterol compared with a group that took optimal standard...
Dallas—After a year of treatment, patients with hypercholesterolemia who received evolocumab plus the standard of care had a mean reduction of 50% in low-density lipoprotein (LDL) cholesterol compared with a group that took optimal standard...
Dallas—After a year of...
01/21/2014
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Starting Specific Biologics Linked With Greater Asthma Burden
05/23/2019
“Real-world data on the characteristics and burden of disease among patients with asthma before receiving asthma-specific biologics would improve the understanding of the use of these therapies in a clinical setting,” researchers wrote.
“Real-world data on the characteristics and burden of disease among patients with asthma before receiving asthma-specific biologics would improve the understanding of the use of these therapies in a clinical setting,” researchers wrote.
“Real-world data on the...
05/23/2019
First Report Managed Care
News
Dems launch $2M pro-reform blitz
09/07/2010
09/07/2010
First Report Managed Care
Oncology Care Model: Delivering Better Care
09/15/2017
The CMS Oncology Care Model turned 1 year old this July.
The CMS Oncology Care Model turned 1 year old this July.
The CMS Oncology Care Model...
09/15/2017
First Report Managed Care
News
Access to Widen on Medicare Data
01/29/2012
01/29/2012
First Report Managed Care
News
Real-World Examples of Benefit Integration Management
03/31/2015
San Diego—During a session at the AMCP meeting, Jennifer Schauer, PharmD, clinical pharmacist, University of Wisconsin Hospital & Clinics, Unity Health Insurance, Madison, Wisconsin, and Elizabeth Kelly, PharmD, clinical manager, pharmacy...
San Diego—During a session at the AMCP meeting, Jennifer Schauer, PharmD, clinical pharmacist, University of Wisconsin Hospital & Clinics, Unity Health Insurance, Madison, Wisconsin, and Elizabeth Kelly, PharmD, clinical manager, pharmacy...
San Diego—During a session at...
03/31/2015
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

January 2014 Volume 11 Issue 1

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement